Exchange: NASDAQ·Updated 03:58 PM EDT
SION logo

SIONSionna Therapeutics Inc

$37.25
$0.52
(1.42%)
Today
EarningsAug 10
Mkt Cap$1.66B
Vol293,858.00
54

Neutral Sentiment

How do you feel about SION?

About

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
59

Frequently Asked Questions

What is Market Cap of Sionna Therapeutics Inc.?
What is the 52-week high for Sionna Therapeutics Inc.?
What is the 52-week low for Sionna Therapeutics Inc.?
What is Sionna Therapeutics Inc. stock price today?
What was Sionna Therapeutics Inc. stock price yesterday?
What is the PE ratio of Sionna Therapeutics Inc.?
What is the Price-to-Book ratio of Sionna Therapeutics Inc.?
What is the 50-day moving average of Sionna Therapeutics Inc.?
How many employees does Sionna Therapeutics Inc. have?

Advertisement|Remove ads.